Fact CheckerSign in

NCT04120298Active, not recruiting

Effects of Exercise in Patients With Metastatic Breast Cancer

Effects of Structured and Individualized Exercise in Patients With Metastatic Breast Cancer on Fatigue and Quality of Life

Source: ClinicalTrials.gov · Last updated 11 May 2026

Brief summary (registry, in English)

Currently, the effect of exercise on metastatic breast cancer has not been extensively studied, even though the benefits are evident in the curative setting. The investigators designed the EFFECT study to assess the effects of a 9-month structured and individualised exercise intervention in 350 patients with metastatic breast cancer (stage IV) on cancer-related physical fatigue, Health-Related Quality of Life (HRQoL), and other disease and treatment-related side effects at six months (primary endpoint).

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
357 (actual)
First submitted
12 Sept 2019
Start date
8 Jan 2020
Primary completion date
28 Feb 2023
Lead sponsor
UMC Utrecht
NCT number
NCT04120298

What you commit to

  • Study type: Interventional
  • Participants enrolled: 357
  • From 8 Jan 2020 to the primary completion date, 28 Feb 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • A potential subject who meets any of the following criteria is not eligible for enrolment into this study:
    • Unstable bone metastases inducing skeletal fragility as determined by the treating clinician
    • Untreated symptomatic known brain metastasis
    • Estimated life expectancy \< 6 months as determined by the treating clinician
    • Serious active infection
    • Too physically active (i.e. \>210 minutes/week of moderate-to-vigorous intentional exercise
    • Severe neurologic or cardiac impairment according ACSM criteria
    • Uncontrolled severe respiratory insufficiency as determined by the treating clinician or if the patient is dependent on oxygen suppletion in rest or during exercise
    • Uncontrolled severe pain
    • Any other contraindications for exercise as determined by the treating physician
    • Any circumstances that would impede adherence to study requirements or ability to give informed consent, as determined by the treating clinician
    • Pregnancy

Who the study is looking for

  • Diagnosis of breast cancer stage IV
  • ECOG (Eastern Cooperative Oncology Group scale) performance status ≤ 2
  • Able and willing to perform the exercise program and wear the activity tracker

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Medical Center Utrecht
Coordinator of this site? Confirm its status
UtrechtNetherlandsUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.